Description     Claims     Drawing  

WO2004105696A   [0011] 

Remington's Pharmaceutical Sciences   [0037] 
Resting and rate-dependent depression of Vmax of guinea-pig ventricular action potentials by amiodarone and desethylamiodarone   [0084] 
Frequency-dependent effect of amiodarone on atrioventricular nodal function and slow-channel action potentials: evidence for calcium channel-blocking activity   [0084] 
BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase   [0084] 
Should amiodarone or lidocaine be given to patients who arrest after cardiac surgery and fail to cardiovert from ventricular fibrillation?   [0084] 
Intravenous amiodarone in intensive care. Time for a reappraisal?   [0084] 
Binding of amiodarone by serum proteins and the effects of drugs, hormones and other interacting ligands   [0084] 
Cardiac □-adrenoreceptor modulation by amiodarone   [0084] 
Pulmonary fibrosis induced in the hamster by amiodarone and desethylamiodarone   [0084] 
Amiodarone pretreatment effects on ischemic isovolumic rat hearts: a P-31 nuclear magnetic resonance study of intracellular pH and high-energy phosphates contents evolutions   [0084] 
Rapid pulmonary phospholipid accumulation induced by intravenous amiodarone Can   [0084] 
Amiodarone pharmacokinetics   [0084] 
Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens   [0084] 
Cellular accumulation of amiodarone and desethylamiodarone in cultured human cells. Consequences of drug accumulation on cellular lipid metabolism and plasma membrane properties of chronically exposed cells   [0084] 
The effect of amiodarone, a new anti-anginal drug, on cardiac muscle   [0084] 
Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats   [0084] 
Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity   [0084] 
Amiodarone pharmacokinetics   [0084] 
Mechanisms of amiodarone and desethylamiodarone cytotoxicity in nontransformed human peripheral lung epithelial cells   [0084] 
Cytotoxic interaction between amiodarone and desethylamiodarone in human peripheral lung epithelial cells   [0084] 
Effects of vitamin E on amiodarone-induced cytotoxicity in isoalted hamster lung cells   [0084] 
Tissue drug accumulation and ultrastructural changes during amiodarone administration in rats   [0084] 
Metastasis: recent discoveries and novel treatment strategies   [0084] 
Distinct mechanisms of tumor invasion and metastasis   [0084] 
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited   [0084] 
Therapy for metastatic melanoma: the past, present, and future   [0084] 
PI3K/Akt signalling pathway and cancer   [0084] 
Protective effect of amiodarone but not N-desethylamiodarone on postichemic hearts by the inhibition of mitochondrial permeability transition   [0084] 
Concentration dependent mitochondrial effect of amiodarone   [0084] 
A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death   [0084] 
Synthesis and evaluation of the permeability transition inhibitory characteristics of paramagnetic and diamagnetic amiodarone derivates   [0084] 
Metastatic inefficiency   [0084] 
Molecular networks that regulate cancer metastasis   [0084] 
Metastasis: a question of life or death   [0084] 
Cancer sternness and metastasis: therapeutic consequences and perspectives   [0084] 
The pro-survival function of Akt kinase can be overridden or altered to contribute to induction of apoptosis   [0084] 
Significance of talin in cancer progression and metastasis   [0084] 
The phosphatidylinositol 3-Kinase AKT pathway in human cancer   [0084] 
The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications   [0084] 
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity   [0084]